Nokia and 3 Indonesia to develop Zero Drive Test assessment solution
By Nikita Chaurasia  Date: 2020-08-21

Nokia and 3 Indonesia to develop Zero Drive Test assessment solution

 

  • Zero Drive Test is a fully automated solution and will replace manual drive testing
  • The new solution to provide detailed analysis of network performance and aids in reducing CO2 emissions.

Nokia Corporation, a multinational telecommunications firm, recently declared that it has partnered with 3 Indonesia to expand and optimize its LTE network capacity as well as coverage in order to fulfill its customer demands through the development of Zero Drive Test solution.

Sources with relevant information stated that the new solution will replace manual drive tests, and further help in reducing CO2 emission levels. Zero Drive Test is fully automated, and will help 3 Indonesia to obtain detailed insights of network performance while improving its user experience.

Zero Drive Test solution reportedly offers a broader perspective as compared to traditional drive tests which provides only the snapshot of analyzed route and network performance.

Committed to sustainability, Nokia has evidently delivered zero-emission products to over 150 customers across the globe since 2019. It also apparently plans to reduce 41% of emissions from its operations by the year 2030.

In this context, Biswas Prosad, Head of Customer Team for Indonesia at Nokia was reported saying that Zero Drive Test solution will aid in providing considerable savings and will allow the company to set an example of their commitment towards sustainability as well as zero emission products.

Desmond Cheung, CTO of 3 Indonesia was reported saying that the company, along with Nokia, will continue to strengthen their network capacity in a bid to improve its user experience. He further added that the deployment of Zero Drive Test solution has helped them to focus on providing improved network quality for their customers.

Zero Drive Test solution is based on Nokia’s AVA Cognitive Services and will enable mobile operators to enhance their business operations and network services through automation and AI (artificial intelligence) applications, sources claimed.

Source-  https://www.nokia.com/about-us/news/releases/2020/08/19/nokia-and-3-indonesia-develop-zero-drive-test-assessment-solution-to-enhance-network-quality-and-user-experience/

About Author

Nikita Chaurasia    

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Fragomen acquires SimpleCitizen to reinforce its immigration services
Fragomen acquires SimpleCitizen to reinforce its immigration services
By Nikita Chaurasia

In a recent turn of events, Fragomen, Del Rey, Bernsen & Loewy, LLP, a leading corporate immigration law company has reportedly joined hands with SimpleCitizen Inc. to form Fragomen Technologies Inc., a new subsidiary which will provide a combina...

Nautilus buys 17 MW portfolio from solar energy developer Pine Gate
Nautilus buys 17 MW portfolio from solar energy developer Pine Gate
By Nikita Chaurasia

Solar project development and asset management major, Nautilus Solar Energy LLC, has reportedly announced its acquisition of two solar portfolios in Rhode Island and Oregon amounting to a total of nearly 17 MW from leading solar energy developer, Pin...

Locate Bio obtains multiple late stage orthobiologics assets from RCSI
Locate Bio obtains multiple late stage orthobiologics assets from RCSI
By Nikita Chaurasia

Regenerative medicine major, Locate Bio, has reportedly announced its in-licensing of several late stage orthobiologics assets from the RCSI University of Medicine and Health Sciences. Sources state that the technologies created by the RCSI Tissue E...

Roche acquires Inflazome to gain control over inflammatory treatments
Roche acquires Inflazome to gain control over inflammatory treatments
By Nikita Chaurasia

In a recent turn of events, Swiss healthcare giant, F. Hoffmann-La Roche AG has reportedly acquired an Irish biotech firm Inflazome Ltd. for approximately USD 451 million (€380 million). As per the agreement, Roche will acquire complete rights ...

Innovent, Eli Lilly release results of ORIENT-11 trial for lung cancer
Innovent, Eli Lilly release results of ORIENT-11 trial for lung cancer
By Nikita Chaurasia

Innovent Biologics Inc., in collaboration with American pharmaceutical giant Eli Lilly and Company, have reportedly announced that the biomarker results of ORIENT-11 trials which were displayed during a mini verbal presentation at ESMO (European Soci...